Bracket Secures $2 Million in Seed Round Funding for Innovative Clinical Trial Technology Services

We are excited to announce that Bracket, a leading provider of clinical trial technology and specialty services, has successfully raised $2,000,000 in funding to enhance our commitment to revolutionizing clinical research. With nine offices and a workforce exceeding 700 employees globally, Bracket is dedicated to empowering bio-pharmaceutical sponsors and contract research organizations with innovative solutions that amplify the efficacy of their clinical research data. The newly acquired funds will be primarily channeled into the development and enhancement of our Bracket eCOA™ platform, which streamlines electronic clinical outcomes assessments, and our Bracket RTSM™, a scalable and configurable clinical IRT solution designed to meet diverse life sciences needs. Additionally, we aim to further refine our Bracket SmartSupplies™ platform, which is instrumental in optimizing the clinical supply chain. The funding will also allow us to expand our Bracket Rater Training and Quality Assurance services, ensuring that our clients receive personalized training and comprehensive quality assurance programs that ultimately enhance their study outcomes. As we move forward, these strategic investments will not only foster innovation and operational excellence within our company but will also contribute significantly to elevating the overall standards of clinical research across the globe. We are grateful for the support of our investors and are eager to leverage this funding to drive impactful change in our industry.